Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
1.760
-0.050 (-2.76%)
At close: Dec 5, 2025, 4:00 PM EST
1.710
-0.050 (-2.84%)
After-hours: Dec 5, 2025, 7:50 PM EST
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $3.29 million as of December 5, 2025. Its market cap has increased by 21.45% in one year.
Market Cap
3.29M
Enterprise Value
-3.86M
1-Year Change
21.45%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $3.29M, a decrease of -98.98%. That is a compound annual growth rate of -68.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 3.39M | -63.73% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |